The National Radium-223 Dichloride Audit Group: Data from Patients in 17 UK Oncology Centres with Metastatic Castrate-resistant Prostate Cancer Treated with Radium-223 Dichloride

Volume: 31, Issue: 2, Pages: e24 - e24
Published: Feb 1, 2019
Abstract
Purpose: The National Radium-223 Dichloride Audit Group comprises clinicians from 17 oncology centres across the UK whose aim is to collect high-quality data from patients with metastatic castrate-resistant prostate cancer (mCRPC) treated with radium-223 dichloride...
Paper Details
Title
The National Radium-223 Dichloride Audit Group: Data from Patients in 17 UK Oncology Centres with Metastatic Castrate-resistant Prostate Cancer Treated with Radium-223 Dichloride
Published Date
Feb 1, 2019
Volume
31
Issue
2
Pages
e24 - e24
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.